Document is current
Any future updates will be listed below
-
Authors
Neth, Bryan J.
Huynh, Kevin https://orcid.org/0000-0001-6170-2207
Giles, Corey https://orcid.org/0000-0002-6050-1259
Wang, Tingting
Mellett, Natalie A.
Duong, Thy https://orcid.org/0000-0002-2521-078X
Blach, Colette
Schimmel, Leyla
Register, Thomas C. https://orcid.org/0000-0002-4078-0166
Blennow, Kaj https://orcid.org/0000-0002-1890-4193
Zetterberg, Henrik
Batra, Richa https://orcid.org/0000-0003-3708-0086
Schweickart, Annalise https://orcid.org/0000-0001-9691-3741
Dilmore, Amanda Hazel
Martino, Cameron https://orcid.org/0000-0001-9334-1258
Arnold, Matthias https://orcid.org/0000-0002-4666-0923
Krumsiek, Jan https://orcid.org/0000-0003-4734-3791
Han, Xianlin https://orcid.org/0000-0002-8615-2413
Dorrestein, Pieter C.
Knight, Rob https://orcid.org/0000-0002-0975-9019
Meikle, Peter J. https://orcid.org/0000-0002-2593-4665
Craft, Suzanne
Kaddurah-Daouk, Rima https://orcid.org/0000-0003-1858-5732
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01AG046171, RF1AG051550, RF1AG057452, R01AG059093, RF1AG058942, U01AG061359, U19AG063744)
Foundation for the National Institutes of Health (#DAOU16AMPA)
- License Information
-
More Information
Article History
Received: 25 July 2023
Accepted: 15 October 2024
First Online: 9 January 2025
Competing interests
: Dr. Kaddurah-Daouk is an inventor on a series of patents on use of metabolomics for the diagnosis and treatment of CNS diseases and holds equity in Metabolon Inc., Chymia LLC and PsyProtix. JK holds equity in Chymia LLC and IP in PsyProtix and is cofounder of iollo. JK holds equity in Chymia LLC and IP in PsyProtix and is cofounder of iollo. Dr. Zetterberg has served at scientific advisory boards and/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Annexon, Apellis, Artery Therapeutics, AZTherapies, CogRx, Denali, Eisai, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, Biogen, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). All other authors declare no competing interests.
